Cipla has voluntarily liquidated wholly-owned step-down subsidiary, Cipla (UK), with effect from March 5, 2021. This liquidation was a part of internal reorganization and it will not affect the performance or revenue of the company.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.
